Melanoma News and Research

Latest Melanoma News and Research

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

Cancer cells that develop resistance to drugs, pay a price for this, by simultaneously developing a new vulnerability. If this acquired vulnerability can be identified, it may be exploited clinically.

10 May 2018

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

Imagine how much patients could benefit if you could discover the presence of cancer, and even how that cancer develops over time, with a simple blood test.

10 May 2018

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute at the University of Utah today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity, a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

Huntsman Cancer Institute (HCI) at the University of Utah (U of U) today announced the opening of the Cancer Population Sciences and Huntsman Center for Health Outcomes and Population Equity (HOPE), a new research and clinical space dedicated to preventing cancer and improving health among underserved populations and improving outcomes in cancer patients.

9 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Castle Biosciences, Inc., the skin cancer diagnostics company providing molecular diagnostics to improve cancer treatment decisions, today announced the presentation of data supporting clinical use of the DecisionDx®-Melanoma test to inform sentinel lymph node biopsy (SLNB) recommendations.

7 May 2018

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

New immunotherapy treatments offer a remarkable chance for survival for patients with advanced melanoma and hard-to-treat cancers of the bladder, kidney and lung.

4 May 2018

Moffitt cancer researchers receive $900,000 grant to study acral melanoma

May is Skin Cancer Awareness Month. More than 5 million people in the United States are diagnosed with the disease each year, making it the most common cancer in our country.

3 May 2018

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

The Cancer Center at Beth Israel Deaconess Medical Center today announced the launch of a new clinical and research institute that will build on BIDMC's long history of leadership in immunotherapy and cell therapeutics.

3 May 2018

AAD encourages early detection of melanoma through skin self-exams

Skin cancer is the most common cancer in the United States. It is estimated that one in five Americans will develop skin cancer in their lifetime, and one person dies from melanoma, the deadliest form of skin cancer, every hour.

3 May 2018

Tanning addiction afflicts teenage minorities in Los Angeles

Tanning addiction plagues teenage minorities in Los Angeles, and that dependency is associated with marijuana abuse, obsessive-compulsive disorder and other mental health issues, a Keck School of Medicine of USC study reports.

2 May 2018

Nearly 50 people present with rare eye cancer - ocular melanoma

At least 50 people have been diagnosed with a rare type of eye cancer called ocular melanoma. They are all residents of two locations - Huntersville, North Carolina, and Auburn, Alabama. The cancer is rare and occurs in only six per 1 million population. The high rate of incidence of this cancer in these two locations has stumped researchers.

2 May 2018

Direct contact with lymphatic endothelial cells promotes melanoma metastasis

Despite the declining death rates for many individual cancer types, mortality for a few cancers has stabilized or even increased. One of these is melanoma due to its ability, in later stages, to spread to other parts of the body.

2 May 2018

More suspected cancer cases can be identified early within primary care

Considerably more cases of suspected cancer can today be identified early within primary care. Partly based on symptoms but also statistics on the patients' visits to health centers, indicates research from Sahlgrenska Academy at University of Gothenburg, Sweden.

27 Apr 2018

Specific type of RNA editing plays key role in protein variation in cancer cells, shows research

A multi-center study led by The University of Texas MD Anderson Cancer Center has shed light on why proteins, the seedlings that serve as the incubator for many cancers, can vary from cancer to cancer and even patient to patient, a discovery that adds to a growing base of knowledge important for developing more effective precision therapies.

27 Apr 2018

Cancer Australia releases new national data on cancer stage at diagnosis

For the first time in Australia, national data on cancer stage at diagnosis is available for the top five incidence cancers – female breast cancer, colorectal, lung, prostate cancers and melanoma.

27 Apr 2018

Study highlights impact of early detection on skin cancer survival

Skin cancer survivors know firsthand that the disease is most treatable when detected early, so they're more likely to be vigilant about skin exams —and new research shows that such vigilance pays off.

26 Apr 2018

Researchers target telomerase for killing NRAS-mutant melanoma cells

Targeting telomerase was effective at killing NRAS-mutant melanoma cells, and the impact was further enhanced when the strategy was paired with an inhibitor of mitochondrial function, according to study results by The Wistar Institute published in Oncogene.

26 Apr 2018

NF-κB1 gene known to drive cancer development is critical for preventing stomach cancers

Melbourne researchers have made the surprise discovery that the 'odd one out' in a family of proteins known to drive cancer development is instead critical for preventing stomach cancers.

24 Apr 2018

Novel gold nanoparticle technology could guide cancer treatment in real-time

A new blood test using gold nanoparticles could soon give oncologists an early and more accurate prognosis of how cancer treatment is progressing and help guide the on-going therapy of patients.

20 Apr 2018

Melanoma News and Research

Latest Melanoma News and Research

New therapeutic strategy exploits acquired vulnerability in drug-resistant cancer

TGen scientists develop new quality-control assay to detect cancer from patient's blood sample

HCI announces opening of Center for HOPE for improving health among underserved populations

Huntsman Cancer Institute opens Cancer Population Sciences and Huntsman Center for HOPE

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

New data supports clinical use of DecisionDx-Melanoma test to inform SLNB options

Ocular oncologists link immunotherapy with potentially vision-robbing side effect

Moffitt cancer researchers receive $900,000 grant to study acral melanoma

Cancer Center at BIDMC announces launch of new Immunotherapy Institute

AAD encourages early detection of melanoma through skin self-exams

Tanning addiction afflicts teenage minorities in Los Angeles

Nearly 50 people present with rare eye cancer - ocular melanoma

Direct contact with lymphatic endothelial cells promotes melanoma metastasis

More suspected cancer cases can be identified early within primary care

Specific type of RNA editing plays key role in protein variation in cancer cells, shows research

Cancer Australia releases new national data on cancer stage at diagnosis

Study highlights impact of early detection on skin cancer survival

Researchers target telomerase for killing NRAS-mutant melanoma cells

NF-κB1 gene known to drive cancer development is critical for preventing stomach cancers

Novel gold nanoparticle technology could guide cancer treatment in real-time

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Melanoma News and Research

Latest Melanoma News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in